Conflict of interest The authors disclose the following relevant interactions with pharmaceutical industry: K. Weller: The author declares that he is or recently was compensated for educational lectures by Essex Pharma (now MSD), Novartis and UCB. N. Schoepke: None. K. Krause: The author declares that she is or recently was compensated for educational lectures by Novartis and Uriach. E. Ardelean: None. M. Bräutigam: The author is employee at Novartis Pharma GmbH. M. Maurer: The author declares that he is or recently was a Speaker and/or Advisor for Almirall Hermal, Essex Pharma, Merckle Recordati, Novartis, Sanofi Aventis, Schering-Plough, MSD, Merck, UCB, and Uriach.
1468-3083/asset/JDV_left.gif?v=1&s=1f5077e9ad670d0243350067014f92a67f0587c2)
ORIGINAL ARTICLE
You have free access to this content
Selected urticaria patients benefit from a referral to tertiary care centres – results of an expert survey
Article first published online: 17 DEC 2011
DOI: 10.1111/j.1468-3083.2011.04387.x
© 2011 The Authors. Journal of the European Academy of Dermatology and Venereology © 2011 European Academy of Dermatology and Venereology
Issue
Journal of the European Academy of Dermatology and Venereology
Volume 27, Issue 1, pages e8–e16, January 2013
Additional Information
How to Cite
Weller, K., Schoepke, N., Krause, K., Ardelean, E., Bräutigam, M. and Maurer, M. (2013), Selected urticaria patients benefit from a referral to tertiary care centres – results of an expert survey. Journal of the European Academy of Dermatology and Venereology, 27: e8–e16. doi: 10.1111/j.1468-3083.2011.04387.x
Funding sources This work was supported by the Urtikaria Network e.V. (UNEV) and Novartis Pharma. The company did not influence the way of data presentation in this work.
Publication History
- Issue published online: 18 DEC 2012
- Article first published online: 17 DEC 2011
- Received: 14 July 2011; Accepted: 17 November 2011
References
- 1, , et al. EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64: 1417–1426.
- 2, , et al. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64: 1427–1443.
- 3, , et al. Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy 2011; 66: 317–330.
- 4, , , , . The impact of chronic urticaria on the quality of life. Br J Dermatol 1997; 136: 197–201.
- 5, , , , . Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life. Br J Dermatol 2005; 152: 289–295.
- 6, , et al. The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings. Allergy 2009; 64: 927–936.
- 7, , , , . Annual direct and indirect health care costs of chronic idiopathic urticaria: a cost analysis of 50 nonimmunosuppressed patients. Arch Dermatol 2008; 144: 35–39.
- 8, . Cost effectiveness of levocetirizine in chronic idiopathic urticaria: a pooled analysis of two randomised controlled trials. Clin Drug Investig 2006; 26: 1–11.
- 9, , et al. Cost intensive, time consuming, problematical? – How physicians in the practice setting experience care of urticaria patients. J Dtsch Dermatol Ges 2011 Nov 23. doi: 10.1111/j.1610-0387.2011.07822.x.
- 10, , et al. Management of chronic spontaneous urticaria in real life – In accordance with the guidelines? A cross-sectional physician based survey study. submitted to J Eur Acad Dermatol Venereol doi: 10.1111/j.1468-3083.2011.04370.x [Epub ahead of print].
- 11, , . General practitioners, dermatologists, allergists, and the management of chronic urticaria. Results of a practice survey. Ann Dermatol Venereol 2003; 130 (Spec No 1): 1S160–1S173.
- 12, , . The natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centre. Br J Dermatol 2002; 146: 110–113.
- 13, , , . Natural course of physical and chronic urticaria and angioedema in 220 patients. J Am Acad Dermatol 2001; 45: 387–391.
- 14, , , , , . Cholinergic urticaria. A clinical and histologic study. Arch Dermatol 1987; 123: 462–467.
- 15, , , , , . Clinical features and natural history of acquired cold urticaria in a tertiary referral hospital: a 10-year prospective study. J Eur Acad Dermatol Venereol 2008; 22: 1405–1411.
- 16, , , . Laboratory tests and identified diagnoses in patients with physical and chronic urticaria and angioedema: a systematic review. J Am Acad Dermatol 2003; 48: 409–416.
- 17
- 18, , , . Pseudoallergen-free diet in the treatment of chronic urticaria. A prospective study. Acta Derm Venereol 1995; 75: 484–487.
- 19, , , , . Effects of a pseudoallergen-free diet on chronic spontaneous urticaria: a prospective trial. Allergy 2010; 65: 78–83.
- 20, , , , , . Frequency and clinical implications of skin autoreactivity to serum versus plasma in patients with chronic urticaria. J Allergy Clin Immunol 2009; 123: 705–706.
- 21, , , , , . EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy 2009; 64: 1256–1268.
- 22, , et al. Food-additive-induced urticaria: a survey of 838 patients with recurrent chronic idiopathic urticaria. Int Arch Allergy Immunol 2005; 138: 235–242.
- 23, , et al. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. J Allergy Clin Immunol 2010; 125: 676–682.
- 24, , . The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg. J Eur Acad Dermatol Venereol 2009; 23: 1088–1091.
- 25, , , , . High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol 2009; 123: 672–679.
- 26. Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed doses. Clin Exp Dermatol 2007; 32: 34–38.
- 27, , , . Acute urticaria: clinical aspects and therapeutic responsiveness. Acta Derm Venereol 1996; 76: 295–297.
- 28, . Outpatient management of acute urticaria: the role of prednisone. Ann Emerg Med 1995; 26: 547–551.